Mycophenolate Mofetil 250 mg/1

Mycophenolate Mofetil 250 mg capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Sandoz Inc in the USA.

Mycophenolate Mofetil is primarily used to prevent rejection of transplanted organs, such as kidneys, hearts, or livers. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness.

Common effects of Mycophenolate Mofetil may include nausea, vomiting, diarrhea, and abdominal pain. Some individuals might experience fatigue, headache, or an increased risk of infections due to its immunosuppressant properties. Always consult a healthcare provider for personalized advice.

Mycophenolate Mofetil should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause harm to an unborn baby. It is important to follow the prescribed dosage and avoid sharing this medication with others. Store the capsules in a cool, dry place away from direct sunlight.

Mycophenolate Mofetil may interact with other medications, including antacids, cholesterol-lowering drugs, and certain antibiotics. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be minimized while using this medication.